5 Mounjaro (Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, & 15 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
Cost effective: Unlike complex electronic monitoring systems such as data loggers, Timestrip indicators are affordable and scalable, making them suitable for widespread deployment
Radiation can benefit infiltrative lipomas, areas at high risk for recurrence, and surgical mass removal with incomplete margins
At MTC, patients are closely monitored through a comprehensive medical weight loss program
continue tretinoin for maintenance